Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

12.150
+0.0200.16%
Volume:6.74M
Turnover:81.39M
Market Cap:31.54B
PE:41.64
High:12.240
Open:12.060
Low:11.900
Close:12.130
52wk High:15.080
52wk Low:6.099
Shares:2.60B
HK Float Shares:2.60B
Volume Ratio:1.25
T/O Rate:0.26%
Dividend:0.17
Dividend Rate:1.44%
EPS(LYR):0.292
ROE:12.45%
ROA:6.50%
PB:3.90
PE(LYR):41.64
PS:3.97

Loading ...

Simcere Pharmaceutical Group - Sim0609 Obtains Clinical Trial Approval in China NY Nmpa

THOMSON REUTERS
·
Sep 08, 2025

Simcere Pharmaceutical Group Ltd. and Jiaxing AnDiCon Biotech Co., Ltd. Secure Acceptance of New Drug Application for Deunoxavir Marboxil Granules by National Medical Products Administration

Reuters
·
Sep 03, 2025

SIMCERE PHARMA (02096): New Drug Application (NDA) for Martenoxavir Granules Accepted by National Medical Products Administration

Stock News
·
Sep 03, 2025

Simcere Pharmaceutical - New Drug Application of Deunoxavir Marboxil Accepted by China's Nmpa for Pediatric Use

THOMSON REUTERS
·
Sep 03, 2025

SIMCERE PHARMA (02096): Accelerating Global Value Creation with HK$1.5+ Billion Placement Signaling Long-term Investment Confidence

Stock News
·
Sep 03, 2025

Simcere Pharma to Raise Nearly HK$1.6 Billion via Share Placement, Top-Up Subscription

MT Newswires Live
·
Sep 02, 2025

BUZZ-Simcere Pharmaceutical falls most in 2-1/2 months on discounted share sale

Reuters
·
Sep 02, 2025

BRIEF-Simcere Pharmaceutical To Issue 121 Million Subscription Shares

Reuters
·
Sep 02, 2025

Simcere Pharmaceutical - to Issue 121 Mln Subscription Shares at HK$12.95 per Share

THOMSON REUTERS
·
Sep 02, 2025

Hong Kong Stock Movement | SIMCERE PHARMA (02096) Surges Over 6% in Morning Session, H1 Revenue Grows Over 15% with Innovative Drug Revenue Share Exceeding Three-Quarters for First Time

Stock News
·
Aug 29, 2025

BRIEF-Simcere Pharmaceutical Says Unit To Buy Entire Assets Of Sanroad Shanghai For RMB17.5 Mln

Reuters
·
Aug 26, 2025

SIMCERE PHARMA (02096) Plans RMB 83.18 Million Acquisition of Shanghai Xiangrui Assets and Xianwei Equity to Rapidly Enter mRNA Technology Sector

Stock News
·
Aug 26, 2025

Simcere Pharmaceutical - Unit to Acquire Entire Assets of Sanroad Shanghai for RMB17.5 Mln, Others

THOMSON REUTERS
·
Aug 26, 2025

Hong Kong Stocks Movement | SIMCERE PHARMA (02096) Surges Over 6% Again, Strong H1 Innovation R&D Results, Dalirexant Expected to Launch Officially This Year

Stock News
·
Aug 25, 2025

Stock Track | SIMCERE PHARMA Soars 5.32% in Pre-market Following Strong H1 Results and Share Buyback Plan

Stock Track
·
Aug 22, 2025

Simcere Pharmaceutical Posts H1 Revenue Of RMB 3,585 Million

Reuters
·
Aug 21, 2025

SIMCERE PHARMA (02096) Reports Interim Results with Net Profit of RMB 604 Million, Up 32.2% YoY

Stock News
·
Aug 21, 2025

BRIEF-Simcere Pharmaceutical To Repurchase Shares Up To RMB500 Mln

Reuters
·
Aug 21, 2025

SIMCERE PHARMA (02096) Plans Share Repurchase

Stock News
·
Aug 21, 2025

Simcere Pharmaceutical Group Ltd - Board Resolves to Repurchase Shares up to RMB500 Mln

THOMSON REUTERS
·
Aug 21, 2025